Recipient NameRandal J. Davis
- The Wellness Center Pharmacy, Inc., dba Designer Drugs
7304 Jarnigan Road
Chattanooga, TN 37421
- Issuing Office:
- Center for Drug Evaluation and Research
4040 N. Central Expressway
Dallas, TX 75204
Dear Mr. Davis:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #2016-NOL-11 dated August 5, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Jose R. Lopez
Acting Director, Compliance Branch
Office of Pharmaceutical Quality Operations